Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSC Vaccine in Metastatic Colorectal Adenocarcinoma
NCT02176746Phase 2Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Jun 2014
- Primary completion
- May 2015
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in colorectal adenocarcinoma (4 arms), sponsored by Fuda Cancer Hospital. Primary endpoint: Adverse events at 3 months. Started Jun 2014; status: completed.
02
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT02176746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176746.